Impact of antipassenger lymphocyte globulin on functional graft survival of discordant xenoislet grafts from a large animal donor.
Troppmann
C
C
Department of Surgery, University of Minnesota Hospital, Minneapolis 55455, USA.
Papalois
B E
BE
Gruessner
A C
AC
Moon
C
C
Matas
A J
AJ
Nakhleh
R E
RE
Gruessner
R W
RW
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D004285:Dogs; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000473:pathology; D011090:Polyenes / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus